Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tonnelet

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Digital Imaging|February 14, 2019
Anthropometer3D: Automatic Multi-Slice Segmentation Software for the Measurement of Anthropometric Parameters from CT of PET/CTPierre Decazes, David Tonnelet, Pierre Vera, et al.
Clinical Nuclear Medicine|May 6, 2020
Diffuse Hypermetabolic Bone Marrow Infiltration in Severe Primary Hyperoxaluria on FDG PETDavid Tonnelet, Khadija Benali, Camille Rasmussen, et al.
Annales Pharmaceutiques Francaises|February 16, 2026
[Implementation of ⁶⁸Ga-FAPI-46 labelling as part of the PRECISION clinical trial.]Noémie Allouche, Amélie Coussirou, David Tonnelet, et al.
Clinical Nuclear Medicine|October 28, 2024
177 Lu-PSMA-617 Radioligand Therapy in Patient With Prostate Cancer Sciatic Nerve MetastasisDavid Tonnelet, Agathe Edet-Sanson, Laetitia Augusto, et al.
EJNMMI Radiopharmacy and Chemistry|May 19, 2026
GMP-compliant automated synthesis and quality control of [<sup>177</sup>Lu]Lu-PSMA-I&T using the GAIA/LUNA Elysia-Raytest module for the treatment of metastatic castration-resistant prostate cancerAmélie Coussirou, Mélodie Six, Agathe Edet-Sanson, et al.
Medical Physics|September 4, 2025
Validation of the collapsed-cone superposition for whole-body patient-specific dosimetry in [177Lu]Lu-PSMA-617 radionuclide therapyAya Terro, Solène Perret, Arthur Dumouchel, et al.
EJNMMI Research|April 13, 2021
Angiogenesis imaging study using interim [<sup>18</sup>F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidenceDavid Tonnelet, M D Pierre Bohn, Stephanie Becker, et al.
EJNMMI Physics|March 20, 2025
Towards fully automatized [177Lu]Lu-PSMA personalized dosimetry based on 360° CZT whole-body SPECT/CT: a proof-of-conceptArnaud Dieudonné, Aya Terro, Arthur Dumouchel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2026
Clinical value of per-treatment whole-body single-time-point automated dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 therapy in metastatic castration-resistant prostate cancerArnaud Dieudonné, Aya Terro, Arthur Dumouchel, et al.
Leukemia & Lymphoma|January 25, 2022
Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective studyVincent Camus, Mathieu Viennot, Emilie Lévêque, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Digital Imaging|February 14, 2019
Anthropometer3D: Automatic Multi-Slice Segmentation Software for the Measurement of Anthropometric Parameters from CT of PET/CTPierre Decazes, David Tonnelet, Pierre Vera, et al.
Clinical Nuclear Medicine|May 6, 2020
Diffuse Hypermetabolic Bone Marrow Infiltration in Severe Primary Hyperoxaluria on FDG PETDavid Tonnelet, Khadija Benali, Camille Rasmussen, et al.
Annales Pharmaceutiques Francaises|February 16, 2026
[Implementation of ⁶⁸Ga-FAPI-46 labelling as part of the PRECISION clinical trial.]Noémie Allouche, Amélie Coussirou, David Tonnelet, et al.
Clinical Nuclear Medicine|October 28, 2024
177 Lu-PSMA-617 Radioligand Therapy in Patient With Prostate Cancer Sciatic Nerve MetastasisDavid Tonnelet, Agathe Edet-Sanson, Laetitia Augusto, et al.
EJNMMI Radiopharmacy and Chemistry|May 19, 2026
GMP-compliant automated synthesis and quality control of [<sup>177</sup>Lu]Lu-PSMA-I&T using the GAIA/LUNA Elysia-Raytest module for the treatment of metastatic castration-resistant prostate cancerAmélie Coussirou, Mélodie Six, Agathe Edet-Sanson, et al.
Medical Physics|September 4, 2025
Validation of the collapsed-cone superposition for whole-body patient-specific dosimetry in [177Lu]Lu-PSMA-617 radionuclide therapyAya Terro, Solène Perret, Arthur Dumouchel, et al.
EJNMMI Research|April 13, 2021
Angiogenesis imaging study using interim [<sup>18</sup>F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidenceDavid Tonnelet, M D Pierre Bohn, Stephanie Becker, et al.
EJNMMI Physics|March 20, 2025
Towards fully automatized [177Lu]Lu-PSMA personalized dosimetry based on 360° CZT whole-body SPECT/CT: a proof-of-conceptArnaud Dieudonné, Aya Terro, Arthur Dumouchel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2026
Clinical value of per-treatment whole-body single-time-point automated dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 therapy in metastatic castration-resistant prostate cancerArnaud Dieudonné, Aya Terro, Arthur Dumouchel, et al.
Leukemia & Lymphoma|January 25, 2022
Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective studyVincent Camus, Mathieu Viennot, Emilie Lévêque, et al.
Pageof 2